Skin conditions (dermatitis, eczema, psoriasis) decisions — 2025

The Board denied an effective date prior to January 24, 2023, for the award of service connection for tinea versicolor.

The Board granted service connection for hypertension and cardiomyopathy as secondary to the Veteran's service-connected lumbar spine and radiculopathy disabilities, with obesity as an intermediate step. The claims for left knee disability, right knee disability, left ankle condition, and eczema were remanded.

The Board remands the claims for service connection for prostate cancer with perineural invasion and skin condition, to include dermatitis, due to inadequate medical opinions.

The Board denied increased ratings for PTSD, left shoulder rotator cuff tear, and dermatitis while granting a 20% rating for the left ankle disability and a 10% rating for the right great toe scar. The Veteran's eligibility for Dependents' Educational Assistance was also denied.

The Board granted a higher initial 30 percent rating for allergic rhinosinusitis and denied or remanded the other issues.

The Board granted a 30 percent rating for bilateral tinea pedis, resolving reasonable doubt in the Veteran's favor.

The Board remands the claim for an additional examination to better reflect the predominant severity of the Veteran's skin condition and to determine if oral medication is considered systemic therapy.

The Board denied the Veteran's appeal for an increased rating in excess of 10 percent for psoriasis, as the evidence did not support a higher rating under the applicable criteria.

The Board granted service connection for hypertension, PTSD, and peripheral neuropathy of the upper and lower extremities effective March 29, 2022. The claim for a back condition was remanded for further development.

The Board granted service connection for anxiety disorder, acne, heart palpitations/mitral valve prolapse, irritable bowel syndrome and esophagitis, left lower extremity radiculopathy, and right lower extremity radiculopathy, effective April 1, 2017. It denied an earlier effective date for migraines, pes planus, plantar fasciitis, and hallux valgus.

The Board denied a compensable rating for sinusitis and remanded the claims for increased ratings for eczema, right knee Osgood-Schlatter disease, and left knee Osgood-Schlatter disease.

The Board granted a 10 percent rating for the Veteran's service-connected eczema with skin lesions, resolving reasonable doubt in favor of the Veteran.

The Board denied a compensable disability rating for pseudofolliculitis barbae (PFB) as the evidence did not show that it affected at least 5 percent of his total body area or exposed area, nor caused disfigurement.

The appeal for service connection for dermatographia and folliculitis has been withdrawn and dismissed.

The Board denied service connection for sleep apnea and a compensable evaluation for tinea pedis. The claims for service connection for a bilateral ear disability, right ankle disability, and right tibia/fibula disability were remanded.

The Board denied the veteran's claims for increased ratings for eczema, migraine headaches, irritable bowel syndrome (IBS), and tinnitus.

The Board dismissed the claim for service connection for atherosclerosis, claimed as coronary artery disease, to include as secondary to diabetes mellitus, type II, due to a prior grant of service connection by the AOJ.

The Board denied service connection for lumbar spine disability, joint pain, cyst, eczema, diarrhea, fatigue, high blood pressure, and tinnitus. The claims for acne, scars, acute pharyngitis, foot pain, headaches, and iliotibial band syndrome were remanded.

The Board granted restoration of a 10 percent evaluation for dermatitis, finding that the Veteran's condition did not reflect actual improvement and that any improvement would not be maintained under ordinary conditions.

The Board denied the veteran's claim for service connection for eczema, finding that there was no evidence of the condition during service or shortly after and that it is not related to his military service.